With a market cap of $95.5 billion, Emerson Electric Co. (EMR) is a global industrial technology and software company. The company is headquartered in St. Louis, Missouri, and specializes in automation, control systems, measurement instrumentation and industrial software. The company provides technologies that help manufacturers and industrial operators improve productivity, operational efficiency, reliability, safety and sustainability across industries such as energy, chemicals, power generation, life sciences, mining, and food and beverage.
Shares of the process control manufacturer have surpassed the broader market over the past 52 weeks. EMR stock has risen 22.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 8.2%. Moreover, shares of the company have gained 17.5% on a YTD basis, outpacing SPX's 7.4% return.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Zooming in further, shares of the company have outperformed the State Street Industrial Select Sector SPDR ETF's (XLI) 6.1% increase over the past 52 weeks and 4.7% rise in 2026.
www.barchart.com Emerson Electric delivered a strong fourth-quarter performance on Nov. 4, supported by accelerating demand for automation technologies, robust order growth and expanding operating margins. Adjusted EPS of $1.86 exceeded the consensus estimate of $1.85, while revenue of $5.20 billion surpassed expectations of approximately $5.11 billion.
Underlying sales, which exclude currency movements and significant acquisitions and divestitures, also increased 7%. Emerson continued to generate healthy cash flow, with operating cash flow increasing 6.3% to $1.08 billion and free cash flow rising 8.7% to $916 million.
The company also announced plans to return approximately $3.8 billion to shareholders in fiscal 2027, including $2.5 billion in share repurchases and $1.3 billion in dividends. Investors were impressed and sent EMR shares up 2.4%.
For the fiscal year ending in September 2027, analysts expect EMR's adjusted EPS to grow 9.3% year over year to $7.20. The company's earnings surprise history is promising. It beat or met the consensus estimates in each of the last four quarters.
Among the 26 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on 16 "Strong Buys," one "Moderate Buy," eight "Holds,” and one "Moderate Sell."
www.barchart.com This configuration is more bullish than two months ago, with 15 “Strong Buy” suggestions on the stock.
On Nov. 5, Bernstein SocGen Group raised its price target on Emerson Electric to $196 from $186 while maintaining an “Outperform” rating. The firm cited Emerson's 14% quarterly order growth, its strongest performance in several years, as a key driver of the revision. Although most quarterly financial results were broadly in line with expectations, the stronger order momentum stood out as a positive indicator of underlying demand.
The mean price target of $181.69 represents an 11.7% premium to EMR’s current price levels. The Street-high price target of $202 suggests a 24.2% potential upside.
On the date of publication, Kritika Sarmah did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
2 Red Flags Supermicro Investors Shouldn’t Ignore After Earnings Nasdaq Futures Climb as Chip Stocks Bounce After Rout; Key U.S. Jobs Report in Focus This Insurance Stock Just Raised Its Dividend by Over 11% This Could be a Major Problem for Alphabet Investors